Comment from Parenteral Drug Association (PDA)

Summary: The Parenteral Drug Association (PDA), a non-profit international professional association, provides specific feedback and proposed revisions to the draft guidance. They argue for greater clarity regarding remote regulatory assessments, more flexibility in response formats, and alignment with international standards like ICH Q9 and Q10.